Pindolol augmentation of treatment-resistant depressed patients

Journal of Clinical Psychiatry

Volumn 58, Issue 10, 1997, Pages 437-439

  Moreno, Francisco A ^a   Gelenberǵ, Alan J ^a   Bachar, Karen ^a   Delǵado, Pedro L ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; DESIPRAMINE; FLUOXETINE; PINDOLOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MIXTURE; DRUG SCREENING; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030697201     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v58n1005     Document Type: Article

References (10)

1. Artigas F, Perez V, Alvarez E. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry 1994;51:248-251
2. Invernizzi R, Belli S, Samanin R. Citalopram's ability to increase the extracellular concentration of serotonin in the dorsal raphe prevents the drug's effect in frontal cortex. Brain Res 1992;584:321-326
3. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study. J Neurochem 1992;60:776-779
4. 1A receptor antagonists in combination therapy: 5-HT and antidepressants: new views from microdialysis studies [letter]. Trends Pharmacol Sci 1993;14:262
5. Blier P, Bergeron R. Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol 1995; 15:217-222
6. Spitzer RL, Williams JBW, Gibbon M, et al. Structured Clinical Interview for DSM-III-R (SCID). New York, NY: Biometric Research, New York State Psychiatric Institute; 1987
7. Mazure CM, Nelson JC, Price LH. Reliability and validity of the symptoms of major depressive illness. Arch Gen Psychiatry 1986;43:451-456
8. Thase ME, Rush AJ. Treatment-resistant depression. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York, NY: Raven Press; 1995:1081-1097
9. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:51-53
10. Rush AJ, Giles DE, Schlesser MA, et al. The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res 1986;18: 65-87